Login / Signup

Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.

Omar ElghawyReema PatelAdam BarsoukJoe PuthumanaJason XuJonathan SussmanBethany HortonVarinder Kaur
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Rechallenge with IO after kidney irAE may be possible in some patients but requires careful evaluation on an individual basis.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • metabolic syndrome
  • adipose tissue
  • patient reported outcomes
  • skeletal muscle
  • insulin resistance
  • weight loss